ax Corp. (NASDAQ:DYAX) will host a webcast and conference call, including an open question and answer session, Thursday, April 25, 2013. During the call, management will discuss the Company’s financial results for the first quarter ended March 31, 2013 and progress regarding its key value drivers - the KALBITOR® (ecallantide) business and angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).
